Autotransfusion System Market by Type, Application, End User

Description

List of Tables

[193 Pages Report] The Autotransfusion System Market size was estimated at USD 493.15 million in 2022 and expected to reach USD 532.52 million in 2023, at a CAGR 8.15% to reach USD 923.65 million by 2030.

Global Autotransfusion System Market

KEY MARKET STATISTICS
Base Year [2022]	USD 493.15 million
Estimated Year [2023]	USD 532.52 million
Forecast Year [2030]	USD 923.65 million
CAGR (%)	8.15%

Autotransfusion systems are medical devices designed for collecting, processing, and reinfusion of the patient's own blood. This process entails collecting blood that has been lost during surgery or trauma, washing and filtering it, and then returning the cleaned blood to the patient. By using the patient's own blood, the risk of transfusion-related complications, such as allergic reactions or transmission of infectious diseases, is significantly reduced. The adoption of autotransfusion systems is increasing to mitigate the pressure on blood bank resources, particularly in times of scarcity or when matching blood types are in short supply. In addition, autotransfusion may be more cost-effective by decreasing the need for donated blood products, which require rigorous testing and storage procedures. The rise in surgical procedures, including cardiovascular, orthopedic, gynecological, and trauma surgeries, makes autotransfusion systems a versatile tool in the operating room. However, stringent regulatory approvals and limited availability of skilled professionals to operate autotransfusion systems limit the product penetration worldwide. Nevertheless, technological advancements in autotransfusion systems that improve efficiency and safety with ongoing investments in healthcare infrastructure are increasing the adoption of autotransfusion systems.

Regional Insights

The Americas represents a highly developing autotransfusion systems market due to the high volume of surgical procedures that require blood transfusions, a strong preference for technologically advanced systems, and investments in innovation and research within the sector. The regional healthcare system prioritizes patient safety and cost-efficiency, leading to a steady need for autotransfusion systems, particularly within the public health sector. In the European Union, the autotransfusion systems market is driven by a well-established healthcare sector and an increasing number of surgeries. Consumers prefer devices that align with EU medical device regulations, emphasizing safety and efficacy. The growing interest in the autotransfusion system in the Middle East and Africa is due to the increasing number of medical tourists and the development of healthcare infrastructure. Asia-Pacific's rapidly growing healthcare sector has prompted significant interest in autotransfusion systems, with the government supporting research and innovation through investments. A keen interest in affordable medical devices and ongoing health initiatives encourage domestic production and research to reduce imports and make autotransfusion systems more accessible to healthcare providers across the Asia-Pacific region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autotransfusion System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autotransfusion System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autotransfusion System Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Carolina Autotransfusion, Inc., Fresenius Medical Care AG & Co. KGaA, Gen World Medical Devices, Getinge AB, Global Blood Resources, LLC, Grifols, S.A., Haemonetics Corporation, i-SEP, Keystone Perfusion, Livanova PLC, Medtronic PLC, ProCell Surgical Inc., Redax S.p.A., Sarstedt AG & Co. KG, Sisu Global Health, SpecialtyCare, Teleflex Incorporated, Terumo Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Autotransfusion System Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Autotransfusion Accessories
- Autotransfusion Products
  - Dual-Mode Autotransfusion Systems
  - Intraoperative Autotransfusion Systems
  - Postoperative Autotransfusion Systems
Application
- Cardiac Surgeries
- Organ Transplantation
- Orthopedic Surgeries
- Trauma Procedures
End User
- Ambulatory Surgical Centers
- Emergency Rooms
- Hospitals
- Nursing Homes
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Autotransfusion System Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autotransfusion System Market?

3. What are the technology trends and regulatory frameworks in the Autotransfusion System Market?

4. What is the market share of the leading vendors in the Autotransfusion System Market?

5. Which modes and strategic moves are suitable for entering the Autotransfusion System Market?

Product Code: MRR-430D42AA0D60

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Autotransfusion System Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Number of Surgical and Transplant Procedures
  - 5.1.1.2. Concern Associated with Blood Safety and Availability
  - 5.1.1.3. Functional and Operational Benefits Associated with Autotransfusion System
- 5.1.2. Restraints
  - 5.1.2.1. High Cost and Limited Availability of Trained Perfusionists and Surgical Technicians
- 5.1.3. Opportunities
  - 5.1.3.1. Potential Utilization of Autotransfusion Systems in Hemothorax Treatments
  - 5.1.3.2. Development of Innovative Autotransfusion Devices
- 5.1.4. Challenges
  - 5.1.4.1. Health Risks Associated with the Autotransfusion Systems
5.2. Market Segmentation Analysis
- 5.2.1. Type: Wide availability of autotransfusion products capable of performing intraoperative and postoperative blood salvage
- 5.2.2. Application: Growing applicability of autotransfusion systems in cardiac surgeries
- 5.2.3. End User: Significant penetration of autotransfusion systems in emergency rooms
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter's Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Autotransfusion System Market, by Type

6.1. Introduction
6.2. Autotransfusion Accessories
6.3. Autotransfusion Products
- 6.4.1. Dual-Mode Autotransfusion Systems
- 6.4.2. Intraoperative Autotransfusion Systems
- 6.4.3. Postoperative Autotransfusion Systems

7. Autotransfusion System Market, by Application

7.1. Introduction
7.2. Cardiac Surgeries
7.3. Organ Transplantation
7.4. Orthopedic Surgeries
7.5. Trauma Procedures

8. Autotransfusion System Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Emergency Rooms
8.4. Hospitals
8.5. Nursing Homes

9. Americas Autotransfusion System Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Autotransfusion System Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Autotransfusion System Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. New Product Launch & Enhancement
  - 12.3.1.1. Haemonetics Introduces Next Generation "Intelligent Control" Software for Cell Saver Elite+ Autotransfusion System
- 12.3.2. Investment & Funding
  - 12.3.2.1. TEDCO Announces Investment into Sisu Global Health
- 12.3.3. Award, Recognition, & Expansion
  - 12.3.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. B. Braun SE
- 13.1.2. Becton, Dickinson and Company
- 13.1.3. Beijing ZKSK Technology Co., Ltd.
- 13.1.4. Braile Biomedica
- 13.1.5. Carolina Autotransfusion, Inc.
- 13.1.6. Fresenius Medical Care AG & Co. KGaA
- 13.1.7. Gen World Medical Devices
- 13.1.8. Getinge AB
- 13.1.9. Global Blood Resources, LLC
- 13.1.10. Grifols, S.A.
- 13.1.11. Haemonetics Corporation
- 13.1.12. i-SEP
- 13.1.13. Keystone Perfusion
- 13.1.14. Livanova PLC
- 13.1.15. Medtronic PLC
- 13.1.16. ProCell Surgical Inc.
- 13.1.17. Redax S.p.A.
- 13.1.18. Sarstedt AG & Co. KG
- 13.1.19. Sisu Global Health
- 13.1.20. SpecialtyCare
- 13.1.21. Teleflex Incorporated
- 13.1.22. Terumo Corporation
- 13.1.23. Zimmer Biomet Holdings, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing